Alteogen Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
7,018
23,316
25,978
37,316
33,432
Total Accounts Receivable
405
1,652
409
1,651
1,454
Inventories
-
-
-
195
216
Other Current Assets
224
220
268
181
568
Total Current Assets
7,646
25,189
26,655
39,343
35,670
Net Property, Plant & Equipment
610
472
4,095
4,729
5,026
Total Investments and Advances
9
12,016
8,080
190
310
Intangible Assets
53
97
181
2,108
601
Other Assets
-
-
-
111
130
Total Assets
8,318
37,958
39,385
47,950
43,013
ST Debt & Current Portion LT Debt
187
754
-
-
-
Accounts Payable
-
-
-
1,507
1,297
Income Tax Payable
7
1
5
45
29
Other Current Liabilities
696
1,073
408
672
1,369
Total Current Liabilities
890
1,828
413
2,224
2,695
Long-Term Debt
1,356
117
-
-
-
Provision for Risks & Charges
-
-
-
3
4
Deferred Taxes
15
184
375
1,467
1,276
Other Liabilities
230
-
-
140
-
Total Liabilities
2,491
1,945
413
2,367
2,699
Common Equity (Total)
5,827
35,707
38,551
45,229
39,845
Total Shareholders' Equity
5,827
35,707
38,551
45,229
39,845
Total Equity
5,827
35,707
38,551
45,229
39,845
Liabilities & Shareholders' Equity
8,318
37,958
39,385
47,950
43,013
Non-Equity Reserves
-
306
421
354
469

About Alteogen

View Profile
Address
62 Yuseong-daero 1628beon-gil
Daejeon DE 34054
Korea, Republic Of
Employees -
Website http://www.alteogen.com
Updated 09/14/2018
Alteogen, Inc. engages in the development, manufacture, and sale of biopharmaceuticals and anticancer drugs. Its products include technologies for anti-breast cancer drug and biosimilar, technology consulting, and other services. The company was founded on May 13, 2008 and is headquartered in Daejeon, South Korea.